# Advanced Manufacturing Technologies In-Person Training Program

Canonical: https://abierto.us/opportunities/fda26pws135129

- Solicitation number: FDA-26-PWS-135129
- Notice type: Combined synopsis and solicitation
- Status: Closed. Deadline was August 4, 2026 at 12:00 PM EDT
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Center for Drug Evaluation and Research (75DKKN)
- NAICS: 813920 Professional Organizations
- Product or service code: AN21 Health R&D Services; Health Research And Training; Basic Research
- Place of performance: Silver Spring, Maryland
- First posted: July 23, 2026
- Last posted: July 23, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/3f3895902d444af99c8727dd2f721f7e/view

## Description

Requiring training in advanced manufacturing technologies — including continuous manufacturing, additive manufacturing, along with platform and modular technologies — represent a significant evolution in pharmaceutical production. These technologies offer the potential to increase manufacturing flexibility and strengthen supply chain resilience.

## Publications

- July 23, 2026: Combined synopsis and solicitation, due August 4, 2026 at 12:00 PM EDT. Notice 3f3895902d444af99c8727dd2f721f7e. https://sam.gov/workspace/contract/opp/3f3895902d444af99c8727dd2f721f7e/view

## Points of contact

- Kyle Smith, kyle.smith@fda.hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/fda26pws135129.